Journal of Law v8n1 2018-8-1
United States Court of Appeals for the Federal Circuit
Supreme Court weighs generic drug dispute - Deseret News
Teva v. Sandoz: Supreme Court Rules That, In Reviewing Patent Claim Constructions on Appeal, Factual Determinations Derived From Extrinsic Evidence Must Be Given “Clearly Erroneous” Deference - Workman Nydegger
The Impact of Teva Pharmaceuticals v. Sandoz on Patent Claim Construction in the District Courts - YouTube
Supreme Court weighs generic drug dispute - Deseret News
Teva Pharmaceuticals v. Sandoz: availability of generic glatiramer acetate and the impact to patent litigation claim constructio
Teva Pharmaceuticals USA, Inc. et al. v. Sandoz, Inc. et al.
Claim Construction, Findings of Fact, and Indefiniteness in the Wake of Teva v. Sandoz | Insights | Jones Day
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
INDEFINITENESS (PRECEDENTIAL) MQC © 2015 O TEVA PHARMACEUTICALS USA v. SANDOZ INC., Appeal No. 2012-1567, -1568, -1569 and -157
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Teva v. Sandoz & The PTAB | Patents Post-Grant
Patent Docs: Supreme Court Grants Certiorari in Teva Pharmaceuticals v. Sandoz
Predicting the Winners in Teva Pharmaceuticals v. Sandoz and Jennings v. Stephens - ISCOTUS now
13A1003 Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc (04/18/2014)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 135 S.Ct. 831 (2015): Case Brief Summary - Quimbee
Teva Pharmaceuticals v. Sandoz: Supreme Court Sides with Teva in Patent Case, Holds That Appeals Court Must Review Factual Findings Underlying Claim Construction for “Clear Error” – Policy & Medicine
IP Alert: Federal Circuit Holds Claims Indefinite Based on Prosecution History in Teva Pharmaceuticals USA v. Sandoz, Inc. - Ban
United States Court of Appeals for the Federal Circuit
Recent Patent Cases July SCOTUS – October 2014 Term Teva Pharmaceuticals v. Sandoz –574 U.S. ___ (2015) Kimble et al. v. Marvel Entertainment – ppt download
Carter Phillips of the Sidley Austin firm representing Mylan Inc. in the case of Teva Pharmaceuticals USA v. Sandoz, departs after arguments at the U.S. Supreme Court in Washington October 15, 2014.
Determining the Standard of Review for Claim Construction: Supreme Court Holds Oral Argument for Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. – S.J. Quinney College of Law
The Adderall supply squeeze in the US is growing
The Appellate Standard of Review for Patent Claim Construction
Intellectual Property Alert:
Patent Docs: Teva v. Sandoz -- Supreme Court Preview
Teva Pharmaceuticals v. Sandoz - Inside the Case - YouTube
